Monday, January 14, 2013

LBI's Landmark, the Shack, Is No More

2010

2010
In the marsh on the eastbound side of the Causeway Bridge was the long-standing and beloved Long Beach Island landmark. The Shack was just a few years shy of a century. It was reported on October 30, 2012 that Sandy's devastation officially destroyed the Shack.

Over the years, I have taken many photographs of the Shack. I hope to add more pics to this post later.

You can read an article by Julie Kaszas-Hoch about the Shack's demise in The SandPaper, January 9, 2013.The article talks about  Ben Wurst, who salvaged pieces of the Shack and is transforming and selling old yellow pine wallboards into cutouts of New Jersey.

Friday, January 11, 2013

Is your sleeping pill putting you at risk?

FDA: Some Sleep Drugs Can Impair Driving


Zolpidem Containing Products: Drug Safety Communication - FDA Requires Lower Recommended Doses


Including Ambien, Ambian CR, Edluar, and Zolpimist

AUDIENCE: Family Practice, Health Professional, Patient

ISSUE: FDA is notifying the public of new information about zolpidem, a widely prescribed insomnia drug. FDA recommends that the bedtime dose be lowered because new data show that blood levels in some patients may be high enough the morning after use to impair activities that require alertness, including driving. This announcement focuses on zolpidem products approved for bedtime use, which are marketed as generics and under the brand names Ambien, Ambien CR, Edluar, and Zolpimist.

FDA is also reminding the public that all drugs taken for insomnia can impair driving and activities that require alertness the morning after use. Drowsiness is already listed as a common side effect in the drug labels of all insomnia drugs, along with warnings that patients may still feel drowsy the day after taking these products. Patients who take insomnia drugs can experience impairment of mental alertness the morning after use, even if they feel fully awake.

For zolpidem products, data show the risk for next-morning impairment is highest for patients taking the extended-release forms of these drugs (Ambien CR and generics). Women appear to be more susceptible to this risk because they eliminate zolpidem from their bodies more slowly than men.

Because use of lower doses of zolpidem will result in lower blood levels in the morning, FDA is requiring the manufacturers of Ambien, Ambien CR, Edluar, and Zolpimist to lower the recommended dose.

FDA is continuing to evaluate the risk of impaired mental alertness with other insomnia drugs, including over-the-counter (OTC) drugs available without a prescription.

FDA prepared a list of questions and answers to provide an additional overview of this safety issue. See the FDA Drug Safety Communication for a Data Summary.

ACKGROUND: Zolpidem is a sedative-hypnotic (sleep) medicine used in adults for the treatment of insomnia. It is marketed as generics and under the brand-names Ambien, Ambien CR, Edluar, Zolpimist, and Intermezzo.

http://www.fda.gov/ForConsumers/ConsumerUpdates/ucm322743.htm   http://consumerhealthchoices.org/catalog/best-buy-drugs-drugs-for-insomnia/

Seasonal Influenza Vaccine Effectiveness

CDC: Early Estimates of Seasonal Influenza Vaccine Effectiveness — United States, January 2013

Here's the link to the CDC report now.




http://www.cdc.gov/mmwr/preview/mmwrhtml/mm62e0111a1.htm?s_cid=mm62e0111a1_e

Tuesday, January 1, 2013

Athena's Coat

Top of coat
 Athena's coat designed by Kyla (6 years of age) using fabric 
from my scrap box and one of Laura's tee shirts as the foundation.
 She chose all the fabric and stitches. She also operated the foot pedal 
on the sewing machine. It was all her idea; she wanted 
to make something that would keep her dog warm. 
The coat ties under Athena's belly and has a Velcro snap for her neck.